MotherToBaby

Medications and More during pregnancy and breastfeeding

Search

866.626.6847

Clonidine

Selected References:

  • Boutroy MJ, et al. 1988. Clonidine: Placental transfer and neonatal adaption. Early Hum Dev 17:275-286.
  • Bunjes R, Schaefer C. 1993. Clonidine and breast-feeding. Clinical Pharm 12:178-9.
  • Frazier, LM, et al. 2020. Emerging therapies for the treatment of neonatal abstinence syndrome. The Journal of Maternal-Fetal & Neonatal Medicine 6:1-9.
  • Horvath JS, et al. 1985. Clonidine hydrochloride a safe and effective antihypertensive agent in pregnancy. Obstet Gynecol 66:634-8.
  • Huisjes, et al. 1986. Is clonidine a behavioural teratogen in the human? Early Hum Dev 14:43-8.
  • Khan A, et al. 1970. Clonidine (Catapres): a new anti-hypertensive agent. Cur Ther Res 12:10.
  • Mirmiran M. 1986. The importance of fetal/neonatal REM sleep. Eur J Obstet Gynecol Reprod Biol 21:283-91.
  • Rothberger S, et al. 2010. Pharmacodynamics of clonidine therapy in pregnancy: a heterogeneous maternal response impacts fetal growth. Am J Hypertens. 23(11):1234-40.
  • Sevrez C, et al. 2014. [Transplacental or breast milk intoxication to clonidine: a case of neonatal hypotonia and drowsiness]. Arch Pediatr. 21(2):198-200.
  • Stoll C, et al. 1979. Robert’s syndrome and clonidine. J Med Genet 16:486-8.
  • Tsai TH, et al. 1982. Teratologic and reproductive studies of lofexidine. Arzneimittelforsh 32:962-6.

This website is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) as part of an award totaling $6,000,000 with zero percentage financed with non-governmental sources. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, HRSA, HHS, or the U.S. Government.